Company
Revolution Medicines
Revolution Medicines has 9 drugs tracked on RxWires: 3 in Phase 3, 1 in Phase 2, 2 in Phase 1/2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| daraxonrasib | Phase 3 | Pancreatic Cancer |
| RMC-6236 | Phase 3 | Pancreatic Cancer |
| Zoldonrasib | Phase 3 | Pancreatic Cancer |
| RMC-4630 | Phase 2 | Non-Small Cell Lung Cancer |
| RMC-6291 | Phase 1/2 | Non-Small Cell Lung Cancer, NSCLC |
| Elironrasib | Phase 1/2 | Non-Small Cell Lung Cancer (NSCLC) |
| RMC-5127 | Phase 1 | Non-small Cell Lung Cancer (NSCLC) |
| RMC-5552 | Phase 1 | Solid Tumors |
| RMC-9805 | Phase 1 | Non-small Cell Lung Cancer (NSCLC) |
Latest
- revolution medicines filed 8-K
- revolution medicines filed 8-K
- revolution medicines filed 8-K
- revolution medicines filed 8-K
- revolution medicines filed 8-K
Follow Revolution Medicines on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.